ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.
Rehman H, Chandrashekar DS, Balabhadrapatruni C, Nepal S, Balasubramanya SAH, Shelton AK, Skinner KR, Ma AH, Rao T, Agarwal S, Eich ML, Robinson AD, Naik G, Manne U, Netto GJ, Miller CR, Pan CX, Sonpavde G, Varambally S, Ferguson JE 3rd.
Rehman H, et al. Among authors: agarwal s.
JCI Insight. 2022 Aug 22;7(16):e155899. doi: 10.1172/jci.insight.155899.
JCI Insight. 2022.
PMID: 35852858
Free PMC article.